We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HITI:NASDAQHigh Tide Inc. Analysis

Data as of 2026-04-08 - not real-time

$2.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its short‑term moving average while the overall trend remains bearish, yet the MACD histogram has turned marginally positive, hinting at a possible short‑term bounce. Volume has been on a downtrend, and recent price action has shown heightened volatility despite a beta that sits comfortably below the market average, suggesting price swings are more company‑specific than market‑driven. The sector environment is fraught with regulatory uncertainty, which amplifies the risk profile, but the company's exposure to the broader cannabis market provides a growth narrative.
Recent earnings released a substantial revenue increase that outpaced consensus, and management outlined an ambitious entry into the UK market, signaling a push for geographic diversification. A discounted cash‑flow analysis places the intrinsic value above the current price, indicating the stock is undervalued with notable upside potential. While cash generation remains modest, operating cash flow is positive, supporting the view that the fundamentals are improving despite ongoing challenges.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • technical indicator showing a tentative bullish shift
  • price positioned below short‑term moving average
  • recent earnings beat providing momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant revenue growth and expansion into new markets
  • undervalued relative to discounted cash‑flow estimate
  • positive operating cash flow supporting sustainability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • long‑term industry tailwinds as cannabis adoption matures
  • strategic brand portfolio and distribution network
  • intrinsic value indicating substantial upside over time

Key Metrics & Analysis

Financial Health

Revenue Growth25.20%
Profit Margin-7.42%
P/E Ratio16.1
ROE-39.72%
ROA3.87%
Debt/Equity110.31
P/B Ratio3.2
Op. Cash Flow$29.0M
Free Cash Flow$7.7M
Industry P/E25.8

Technical Analysis

TrendBearish
RSI42.4
Support$2.18
Resistance$2.70
MA 20$2.35
MA 50$2.39
MA 200$2.75
MACDBullish
VolumeDecreasing
Fear & Greed Index85.21

Valuation

Fair Value$2.37
Target Price$5.67
Upside/Downside148.54%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.73
Volatility32.15%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.